Apr 16, 2018 Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating the Ability of its PDCs to Selectively Target a Broad Range of Tumor Cells Learn More
Apr 16, 2018 Preclinical Data Highlighting Uptake and Enhanced Anti-Tumor Effects of Cellectar’s CLR 131 in Head and Neck Cancer Presented at AACR Annual Meeting Learn More
Apr 3, 2018 Cellectar Announces Issuance of U.S. Patent Covering CLR 131 Use in Multiple Myeloma Learn More